Welcome to our dedicated page for Spotify Tech SEC filings (Ticker: SPOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Royalty accruals, churn metrics, and multi-currency revenues make Spotify Technology’s SEC documents anything but light reading. If you’ve ever searched, “Spotify Technology SEC filings explained simply,” you already know how dense a single 10-K can be.
Stock Titan solves that problem. Our AI reviews every annual report 10-K, quarterly earnings report 10-Q filing, and 8-K material events within minutes of hitting EDGAR, then highlights what investors actually look for—content licensing costs, premium subscriber trends, and podcast acquisition impacts. Need to monitor Spotify Technology insider trading Form 4 transactions? Get real-time alerts so you can spot buying or selling patterns before the market digests them.
Use cases include:
- Comparing segment margins across regions without combing through footnotes
- Flagging executive stock grants via “Spotify Technology executive stock transactions Form 4”
- Reviewing proxy statement disclosures on talent compensation in one scroll
Each filing comes with an AI-powered summary that turns streaming-royalty jargon into plain English, letting professionals focus on decisions, not deciphering. Whether you type “understanding Spotify Technology SEC documents with AI” or “Spotify Technology earnings report filing analysis,” all paths lead here—complete coverage, updated instantly, and explained clearly.
Atlas Venture funds have filed Amendment No. 1 to their Schedule 13D for ImageneBio, Inc. (formerly Ikena Oncology, Nasdaq: IKNA) to report dilution of their holdings after the 1-for-12 reverse stock split and completion of Ikena’s all-stock merger with Inmagene on 25 Jul 2025.
- Collectively, the reporting entities now own 418,179 post-split common shares, equal to 3.6 % of the 11.6 million shares outstanding.
- Breakdown: Fund X 241,800 shares (2.1 %), Fund XI 103,494 shares (0.9 %), Opportunity Fund I 72,885 shares (0.6 %).
- All voting and dispositive powers are shared among the respective limited partnerships and their general partners; no sole voting power is reported.
- The funds ceased to be 5 % beneficial owners on 25 Jul 2025; no purchases or sales occurred in the past 60 days.
- Purpose: administrative update reflecting dilution from the merger and reverse split; Atlas Venture continues to hold the same absolute number of economic shares pre-transaction but a lower percentage.
Atlas Venture disclaims group status among the reporting persons. A joint filing agreement is included as Exhibit 99.1.
On 29 Jul 2025 Coastal Financial Corporation (Nasdaq: CCB) filed a Form 8-K to disclose that it has posted an investor presentation on its website and furnished it as Exhibit 99.1 under Item 7.01 (Regulation FD). The slides will be used in upcoming investor meetings and are provided for informational purposes only. As a furnished, not filed, exhibit, the materials are not subject to Exchange Act §18 liabilities and are not automatically incorporated into the company’s other SEC filings. No new financial results, guidance, or transaction details are contained in this filing. The company also included the Inline XBRL cover page file (Exhibit 104). The 8-K was signed by EVP & CFO Joel G. Edwards.